Cargando…
VMAT testing for an Elekta accelerator
Volumetric‐modulated arc therapy (VMAT) has been shown to be able to deliver plans equivalent to intensity‐modulated radiation therapy (IMRT) in a fraction of the treatment time. This improvement is important for patient immobilization/ localization compliance due to comfort and treatment duration,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716421/ https://www.ncbi.nlm.nih.gov/pubmed/22402389 http://dx.doi.org/10.1120/jacmp.v13i2.3725 |
_version_ | 1783283949760413696 |
---|---|
author | Kaurin, Darryl G.L. Sweeney, Larry E. Marshall, Edward I. Mahendra, Saikanth |
author_facet | Kaurin, Darryl G.L. Sweeney, Larry E. Marshall, Edward I. Mahendra, Saikanth |
author_sort | Kaurin, Darryl G.L. |
collection | PubMed |
description | Volumetric‐modulated arc therapy (VMAT) has been shown to be able to deliver plans equivalent to intensity‐modulated radiation therapy (IMRT) in a fraction of the treatment time. This improvement is important for patient immobilization/ localization compliance due to comfort and treatment duration, as well as patient throughput. Previous authors have suggested commissioning methods for this modality. Here, we extend the methods reported for the Varian RapidArc system (which tested individual system components) to the Elekta linear accelerator, using custom files built using the Elekta iComCAT software. We also extend the method reported for VMAT commissioning of the Elekta accelerator by verifying maximum values of parameters (gantry speed, multileaf collimator (MLC) speed, and backup jaw speed), investigating: 1) beam profiles as a function of dose rate during an arc, 2) over/under dosing due to MLC reversals, and 3) over/under dosing at changing dose rate junctions. Equations for construction of the iComCAT files are given. Results indicate that the beam profile for lower dose rates varies less than 3% from that of the maximum dose rate, with no difference during an arc. The gantry, MLC, and backup jaw maximum speed are internally consistent. The monitor unit chamber is stable over the MUs and gantry movement conditions expected. MLC movement and position during VMAT delivery are within IMRT tolerances. Dose rate, gantry speed, and MLC speed are accurately controlled. Over/under dosing at junctions of MLC reversals or dose rate changes are within clinical acceptability. PACS numbers: 87.55.de, 87.55.Qr, 87.56.bd |
format | Online Article Text |
id | pubmed-5716421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57164212018-04-02 VMAT testing for an Elekta accelerator Kaurin, Darryl G.L. Sweeney, Larry E. Marshall, Edward I. Mahendra, Saikanth J Appl Clin Med Phys Radiation Oncology Physics Volumetric‐modulated arc therapy (VMAT) has been shown to be able to deliver plans equivalent to intensity‐modulated radiation therapy (IMRT) in a fraction of the treatment time. This improvement is important for patient immobilization/ localization compliance due to comfort and treatment duration, as well as patient throughput. Previous authors have suggested commissioning methods for this modality. Here, we extend the methods reported for the Varian RapidArc system (which tested individual system components) to the Elekta linear accelerator, using custom files built using the Elekta iComCAT software. We also extend the method reported for VMAT commissioning of the Elekta accelerator by verifying maximum values of parameters (gantry speed, multileaf collimator (MLC) speed, and backup jaw speed), investigating: 1) beam profiles as a function of dose rate during an arc, 2) over/under dosing due to MLC reversals, and 3) over/under dosing at changing dose rate junctions. Equations for construction of the iComCAT files are given. Results indicate that the beam profile for lower dose rates varies less than 3% from that of the maximum dose rate, with no difference during an arc. The gantry, MLC, and backup jaw maximum speed are internally consistent. The monitor unit chamber is stable over the MUs and gantry movement conditions expected. MLC movement and position during VMAT delivery are within IMRT tolerances. Dose rate, gantry speed, and MLC speed are accurately controlled. Over/under dosing at junctions of MLC reversals or dose rate changes are within clinical acceptability. PACS numbers: 87.55.de, 87.55.Qr, 87.56.bd John Wiley and Sons Inc. 2012-03-08 /pmc/articles/PMC5716421/ /pubmed/22402389 http://dx.doi.org/10.1120/jacmp.v13i2.3725 Text en © 2012 The Authors. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Kaurin, Darryl G.L. Sweeney, Larry E. Marshall, Edward I. Mahendra, Saikanth VMAT testing for an Elekta accelerator |
title | VMAT testing for an Elekta accelerator |
title_full | VMAT testing for an Elekta accelerator |
title_fullStr | VMAT testing for an Elekta accelerator |
title_full_unstemmed | VMAT testing for an Elekta accelerator |
title_short | VMAT testing for an Elekta accelerator |
title_sort | vmat testing for an elekta accelerator |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716421/ https://www.ncbi.nlm.nih.gov/pubmed/22402389 http://dx.doi.org/10.1120/jacmp.v13i2.3725 |
work_keys_str_mv | AT kaurindarrylgl vmattestingforanelektaaccelerator AT sweeneylarrye vmattestingforanelektaaccelerator AT marshalledwardi vmattestingforanelektaaccelerator AT mahendrasaikanth vmattestingforanelektaaccelerator |